Dupixent (dupilumab) is an FDA-approved prescription medication that is primarily used to treat moderate to severe eczema, or atopic dermatitis, in adults and children ages 6 months and older.1, 2, 3 Dupixent comes in the form of a liquid solution that is self-administered via subcutaneous injections every one to four weeks.1 It can also be prescribed to treat eosinophilic or oral-corticosteroid-dependent asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, chronic obstructive pulmonary disease (COPD), and prurigo nodularis.1, 2, 3
We do not currently prescribe Dupixent, but our board-certified online doctors are happy to discuss other personalized treatment options with you.
Who is a candidate for Dupixent?
The FDA has approved Dupixent (dupilumab) in adults and children 6 months old and up who have moderate to severe eczema that has not improved with the use of topical medications, or where topicals are contraindicated.1, 3, 6
When treating moderate to severe asthma, Dupixent can be prescribed to adults and children aged 6 years and older; for eosinophilic esophagitis (EoE), it can be used in people ages 1 year and up, and for chronic rhinosinusitis, people 12 years of age and older can use Dupixent.3, 5 Only adults 18 and up may be prescribed Dupixent for the treatment of COPD or prurigo nodularis.3, 6